Short Interest in Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Decreases By 44.8%

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) was the target of a large drop in short interest in March. As of March 15th, there was short interest totalling 27,000 shares, a drop of 44.8% from the February 28th total of 48,900 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Laboratorios Farmaceuticos Rovi Price Performance

LABFF stock remained flat at C$65.86 during trading on Friday. The company has a 50 day moving average of C$65.86 and a 200-day moving average of C$75.21. Laboratorios Farmaceuticos Rovi has a 1 year low of C$65.86 and a 1 year high of C$65.86.

About Laboratorios Farmaceuticos Rovi

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.